- Home
- AVPT vs RCKT Comparison
AVPT vs RCKT Comparison
Compare AVPT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVPT
- RCKT
- Stock Information
- Founded
- AVPT 2001
- RCKT 1999
- Country
- AVPT United States
- RCKT United States
- Employees
- AVPT N/A
- RCKT N/A
- Industry
- AVPT Computer Software: Prepackaged Software
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- AVPT Technology
- RCKT Health Care
- Exchange
- AVPT Nasdaq
- RCKT Nasdaq
- Market Cap
- AVPT 3.8B
- RCKT 328.6M
- IPO Year
- AVPT N/A
- RCKT N/A
- Fundamental
- Price
- AVPT $15.96
- RCKT $3.17
- Analyst Decision
- AVPT Buy
- RCKT Buy
- Analyst Count
- AVPT 4
- RCKT 13
- Target Price
- AVPT $19.75
- RCKT $12.96
- AVG Volume (30 Days)
- AVPT 1.2M
- RCKT 2.8M
- Earning Date
- AVPT 11-06-2025
- RCKT 11-06-2025
- Dividend Yield
- AVPT N/A
- RCKT N/A
- EPS Growth
- AVPT N/A
- RCKT N/A
- EPS
- AVPT N/A
- RCKT N/A
- Revenue
- AVPT $373,069,000.00
- RCKT N/A
- Revenue This Year
- AVPT $26.16
- RCKT N/A
- Revenue Next Year
- AVPT $18.18
- RCKT $108.43
- P/E Ratio
- AVPT N/A
- RCKT N/A
- Revenue Growth
- AVPT 24.41
- RCKT N/A
- 52 Week Low
- AVPT $11.43
- RCKT $2.19
- 52 Week High
- AVPT $20.25
- RCKT $22.00
- Technical
- Relative Strength Index (RSI)
- AVPT 48.63
- RCKT 48.10
- Support Level
- AVPT $15.13
- RCKT $3.09
- Resistance Level
- AVPT $16.06
- RCKT $3.29
- Average True Range (ATR)
- AVPT 0.49
- RCKT 0.15
- MACD
- AVPT 0.04
- RCKT -0.02
- Stochastic Oscillator
- AVPT 50.61
- RCKT 37.94
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.